Under-representation of women in stroke randomized controlled trials: Inadvertent selection bias leading to suboptimal conclusions

Therapeutic Advances in Neurological Disorders

Volumn 10, Issue 5, 2017, Pages 241-244

  Tsivgoulis, Georgios ^a   Katsanos, Aristeidis H ^a,b   Caso, Valeria ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; TISSUE PLASMINOGEN ACTIVATOR;

ATRIAL FIBRILLATION; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; COHORT ANALYSIS; DISEASE ASSOCIATION; HUMAN; INTRAVENOUS THROMBOLYSIS; LETTER; MECHANICAL THROMBECTOMY; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SECONDARY PREVENTION; SEX DIFFERENCE;

EID: 85019084022     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285617699588     Document Type: Letter

References (34)

1. Reeves M, Bhatt A, Jajou P, et al. Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis. Stroke 2009; 40: 1743-1749.
2. de Ridder I, Dirks M, Niessen L, et al. Unequal access to treatment with intravenous alteplase for women with acute ischemic stroke. Stroke 2013; 44: 2610-2612.
3. Madsen TE, Sucharew H, Katz B, et al. Gender and time to arrival among ischemic stroke patients in the Greater Cincinnati/Northern Kentucky Stroke Study. J Stroke Cerebrovasc Dis 2016; 25: 504-510.
4. Perren F, Eriksson A, Jonsson AC, et al. Older women benefit from thrombolysis as much as older men. J Stroke Cerebrovasc Dis 2016; 25: 1882-1886.
5. Sacco S, Cerone D, Carolei A., Gender and stroke: acute phase treatment and prevention. Funct Neurol 2009; 24: 45-52.
6. Lasek-Bal A, Puz P, Kazibutowska Z., Efficacy and safety assessment of alteplase in the treatment of stroke: gender differences. Neurol Res 2014; 36: 851-856.
7. Savitz SI, Schlaug G, Caplan L, et al. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke 2005; 36: 1447-1451.
8. Hametner C, Kellert L, Ringleb PA., Impact of sex in stroke thrombolysis: a coarsened exact matching study. BMC Neurol 2015; 15: 10.
9. Lorenzano S, Ahmed N, Falcou A, et al. Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answers from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register. Stroke 2013; 44: 3401-3406.
10. Clua-Espuny JL, Ripolles-Vicente R, Forcadell-Arenas T, et al. Sex differences in long-term survival after a first stroke with intravenous thrombolysis: Ebrictus study. Cerebrovasc Dis Extra 2015; 5: 95-102.
11. Spaander FH, Zinkstok SM, Baharoglu IM, et al. Sex differences and functional outcome after intravenous thrombolysis revision. Stroke. Epub ahead of print 31 2017. DOI: 10.1161/STROKEAHA.116.014739.
12. Kent DM, Price LL, Ringleb P, et al. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke 2005; 36: 62-65.
13. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384: 1929-1935.
14. Fransen PSS, Beumer D, Berkhemer OA, et al. Sex differences in effect of intra-arterial treatment for acute ischemic stroke: a MR CLEAN post-hoc analysis (ESOC-1009). Int J Stroke 2015; 10: 5.
15. Campbell BC, Hill MD, Rubiera M, et al. Safety and efficacy of solitaire stent thrombectomy: individual patient data meta-analysis of randomized trials. Stroke 2016; 47: 798-806.
16. Bush CK, Kurimella D, Cross LJ, et al. Endovascular treatment with stent-retriever devices for acute ischemic stroke: a meta-analysis of randomized controlled trials. PLoS One 2016; 11: e0147287.
17. Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016; 387: 1723-1731.
18. Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11-20.
19. Giannopoulos S, Katsanos AH, Vasdekis SN, et al. Age and gender disparities in the risk of carotid revascularization procedures. Neurol Sci 2013; 34: 1711-1717.
20. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915-924.
21. Chambers BR, Donnan GA., Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev 2005; 4: CD001923. DOI: 10.1002/14651858.CD001923.pub2.
22. Bond R, Rerkasem K, Shearman CP, et al. Time trends in the published risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Cerebrovasc Dis 2004; 18: 37-46.
23. Howard VJ, Voeks JH, Lutsep HL, et al. Does sex matter? Thirty-day stroke and death rates after carotid artery stenting in women versus men: results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) lead-in phase. Stroke 2009; 40: 1140-1147.
24. Howard VJ, Lutsep HL, Mackey A, et al. Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol 2011; 10: 530-537.
25. Touze E, Trinquart L, Chatellier G, et al. Systematic review of the perioperative risks of stroke or death after carotid angioplasty and stenting. Stroke 2009; 40: e683-e693.
26. De Rango P, Brown MM, Leys D, et al. Management of carotid stenosis in women: consensus document. Neurology 2013; 80: 2258-2268.
27. Santalucia P, Pezzella FR, Sessa M, et al. Sex differences in clinical presentation, severity and outcome of stroke: results from a hospital-based registry. Eur J Intern Med 2013; 24: 167-171.
28. Katsanos AH, Mavridis D, Parissis J, et al. Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis. Ther Adv Neurol Disord 2016; 9: 359-368.
29. Tanahashi N, Hori M, Matsumoto M, et al. Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation for the secondary prevention of stroke: a subgroup analysis of J-ROCKET AF. J Stroke Cerebrovasc Dis 2013; 22: 1317-1325.
30. Homma S, Thompson JL, Pullicino PM, et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 2012; 366: 1859-1869.
31. Caso V, Santalucia P, Acciarresi M, et al. Antiplatelet treatment in primary and secondary stroke prevention in women. Eur J Intern Med 2012; 23: 580-585.
32. Melloni C, Berger JS, Wang TY, et al. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes 2010; 3: 135-142.
33. Berger JS, Roncaglioni MC, Avanzini F, et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006; 295: 306-313.
34. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989; 321: 129-135.